Immune biomarkers predictive of respiratory viral infection in elderly nursing home residents

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Johnstone, Jennie ^a   Parsons, Robin ^b   Botelho, Fernando ^b   Millar, Jamie ^b   McNeil, Shelly ^c   Fulop, Tamas ^d   McElhaney, Janet ^e   Andrew, Melissa K ^c   Walter, Stephen D ^a   Devereaux, P J ^a   Malekesmaeili, Mehrnoush ^f   Brinkman, Ryan R ^f,g   Mahony, James ^a   Bramson, Jonathan ^a,b   Loeb, Mark ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITÉ DE SHERBROOKE   (Canada)

^e NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

^f BRITISH COLUMBIA CANCER AGENCY   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AGE DISTRIBUTION; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; CORONAVIRUS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN METAPNEUMOVIRUS; IMMUNOPHENOTYPING; INFLUENZA VIRUS; MAJOR CLINICAL STUDY; MALE; NURSING HOME PATIENT; OUTCOME ASSESSMENT; PARAINFLUENZA VIRUS; PREDICTION; REGULATORY T LYMPHOCYTE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY VIRUS; RHINOVIRUS; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY; VIRAL RESPIRATORY TRACT INFECTION; VIRUS IDENTIFICATION; CANADA; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; IMMUNOLOGY; METABOLISM; MULTIVARIATE ANALYSIS; NURSING HOME; PHENOTYPE; RESPIRATORY TRACT INFECTION; T LYMPHOCYTE; TIME FACTOR; VIROLOGY;

AGED; AGED, 80 AND OVER; BIOMARKERS; CANADA; COHORT STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NURSING HOMES; PHENOTYPE; RESPIRATORY TRACT INFECTIONS; T-LYMPHOCYTES; TIME FACTORS;

EID: 84907481710     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108481     Document Type: Article

References (56)

1. Falsey A, Dallal G, Formica M, Andolina G, Hamer D, et al. (2008) Long-term care facilities: a cornucopia of viral pathogens. J Am Geriatr Soc 56:1281-1285.
2. Loeb M, McGeer A, McArthur M, Peeling RW, Petric M, et al. (2000) Surveillance for outbreaks of respiratory tract infections in nursing homes. CMAJ 162:1133-1137.
3. Drinka P, Gravenstein S, Langer E, Krause P, Shult P (1999) Mortality following isolation of various respiratory viruses in nursing home residents. Infect Control Hosp Epidemiol 20:812-815.
4. Louie J, Yagi S, Nelson F, Kiang D, Glaser C, et al. (2005) Rhinovirus outbreak in a long-term care facility for elderly persons associated with unusually high mortality. Clin Infect Dis 41:262-265.
5. Hicks L, Shepard C, Britz P, Erdman D, Fischer M, et al. (2006) Two outbreaks of severe respiratory disease in nursing homes associated with rhinovirus. J Am Geriatr Soc 54:284-289.
6. Falsey A, McCann R, Hall W, Criddle M, Formica M, et al. (1997) The "common cold" in frail older person: impact of rhinovirus and coronavirus in a senior daycare center. J Am Geriatr Soc 45:706-711.
7. Boivin G, De Serres G, Hamelin M, Côté S, Argouin M, et al. (2007) An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin Infect Dis 44:1152-1158.
8. Smith P, Bennett G, Bradley S, Drinka P, Lautenbach E, et al. (2008) SHEA/APIC Guideline: Infection prevention and control in the long-term care facility; Society for Healthcare Epidemiology of America (SHEA); Association for Professionals in Infection Control and Epidemiology (APIC). Am J Infect Control 36:504-535.
9. Fulop T, Pawelec G, Castle S, Loeb M (2009) Immunosenescence and vaccination in nursing home residents. Clin Infect Dis 48:443-448.
10. Johnstone J, Millar J, Lelic A, Verschoor C, Walter S, et al. (2014) Immunosenescence in the nursing home elderly. BMC Geriatrics 14:50.
11. Saule P, Trauet J, Dutriez V, Lekeux V, Dessaint J, et al. (2006) Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4+ versus effector memory and terminally differentiated memory cells in CD8+ compartment. Mech Ageing Dev 127:274-281.
12. Fahey J, Schnelle J, Boscardin J, Thomas J, Gorre M, et al. (2000) Distinct categories of immunologic changes in frail elderly. Mech Ageing Dev 115:1-20.
13. Effros R, Boucher N, Porter V, Zhu X, Spaulding C, et al. (1994) Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenecence. Exp Gerontol 29:601-609.
14. Boucher N, Dufeu-Duchesne T, Vicaut E, Farge D, Effros R, et al. (1998) CD28 expression in T cell aging and human longevity. Exp Gerontol 33:267-282.
15. Wikby A, Johansson B, Olsson J, Löfgren S, Nilsson B, et al. (2002) Expansion of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 37:445-453.
16. Looney R, Falsey A, Campbell D, Torres A, Kolassa J, et al. (1999) Role of cytomegalovirus in the T-cell changes seen in elderly individuals. Clin Immunol 90:213-219.
17. Fulop T, Larbi A, Wikby A, Mocchegiani E, Hirokawa K, et al. (2005) Dysregulation of T-cell function in the elderly: scientific basis and clinical implications. Drugs Aging 22:589-603.
18. Goronzy J, Fulbright J, Crowson C, Poland G, O'Fallon W, et al. (2001) Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 75:12182-12187.
19. Saurwein-Teissl M, Lung T, Marx F, Gschösser C, Asch E, et al. (2002) Lack of antibody production following immunization in old age: association with CD8+ CD28-T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 168:5893-5899.
20. Trzonkowski P, Mysliwska J, Szmit E, Wieckiewicz J, Lukaszuk K, et al. (2003) Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination - an impact of immunosenescence. Vaccine 21:3826-3836.
21. Wang L, Xie Y, Zhu L, Chang T, Mao Y, et al. (2010) An association between immunosenescence and CD4+CD25+ regulatory T-cells: a systematic review. Biomed Environ Sci 23:327-332.
22. Rowe J, Ertelt J, Way S (2012) Foxp3+ regulatory T-cells, immune stimulation and host defence against infection. Immunology 136:1-10.
23. Rockwood K, Abeysundera M, Mitnitski A (2007) How should we grade frailty in nursing home patients? J Am Med Dir Assoc 8:595-603.
24. Langley J, Warshawsky B, Ismail S, Crowcroft N, Hanrahan A, et al. (2009) Statement on seasonal trivalent inactivated influenza vaccine for 2009-2010. CCDR 35: ACS-6.
25. Langley J, Warshawsky B, Ismail S, Crowcroft N, Hanrahan A, et al. (2010) Statement on seasonal trivalent inactivated influenza vaccine for 2010-2011. CCDR 36: ACS-6.
26. Langley J, Warshawsky B, Cooper C, Crowcroft N, Hanrahan A, et al. (2011) Statement on seasonal trivalent inactivated influenza vaccine for 2011-2012. CCDR 37: ACS-5.
27. Disis M, dela Rosa C, Goodell V, Kuan L, Chang J, et al. (2006) Maximizing the retention of antigen specific lymphocyte function after cryopreservation. J Immunol 308:13-18.
28. Lelic A, Verschoor C, Ventresca M, Parsons R, Evelegh C, et al. (2012) The polyfunctionality of human memory CD8+ T cells elicited by acute and chronic virus infections is not influenced by age. PLoS Pathog 8:e1003076.
29. Verschoor C, Johnstone J, Millar J, Dorrington M, Habibagahi M, et al. (2013) Blood CD33 (+) HLA-DR (-) myeloid-derived suppressor cells are increased with age and a history of cancer. J Leukoc Biol 93:633-637.
30. Submitted as an R package in Bioconductor: An open source, open development software project to provide tools for the analysis and comprehension of highthroughput genomic data.
31. Marshall A, Altman D, Holder R (2010) Comparison of imputation methods for handling missing covariate data when fitting a Cox proportional hazards model: a resampling study. BMC Med Res Methodol 31:112.
32. Fulop T, Larbi A, Witkowski J, McElhaney J, Loeb M, et al. (2010) Aging, frailty and age-related disease. Biogerontology 11:547-563.
33. Wei L, Lin D, Weissfeld L (1989) Regression-analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 84:1065-1073.
34. R Core Team (2013) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. Available: http://www. R-project.org/.
35. Keynan Y, Card C, McLaren P, Dawood M, Kasper K, et al. (2008) The role of regulatory T-cells in chronic and acute viral infections. Clin Infect Dis 46:1046-1052.
36. Lages C, Suffia I, Velilla P, Huang B, Warshaw G, et al. (2008) Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol 181:1835-1848.
37. Betts R, Prabhu N, Ho A, Lew F, Hutchinson P, et al. (2012) Influenza A virus infection results in a robust, antigen-responsive, and widely disseminated Fox3+ regulatory T cell response. J Virol 86:2817-2825.
38. Fulton R, Meyerholz D, Varga S (2010) Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J Immunol 185:2382-2392.
39. Williams-Bey Y, Jiang J, Murasko D (2011) Expansion of regulatory T cells in aged mice following influenza infection. Mech Ageing Dev 132:163-170.
40. Koch S, Larbi A, Ozcelik D, Solana R, Gouttefangeas C, et al. (2007) Cytomegalovirus: A driving force in human T-cell immunosenescence. Ann NY Acad Sci 1114:23-25.
41. Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A, et al. (2009) Cytomegalovirus and human immunosenescence. Rev Med Virol 19:47-56.
42. den Elzen W, Vossen A, Cools H, Westendorp R, Kroes A, et al. (2011) Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. Vaccine 29:4869-4874.
43. Derhovanessian E, Theeten H, Hahnel K, Van Damme P, Cools N, et al. (2013) Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. Vaccine 31:685-690.
44. McElhaney J, Zhou X, Talbot H, Soethout E, Bleackley R, et al. (2012) The unmet need in the elderly: How immunosenescence, CMV infection, comorbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 30:2060-2067.
45. Sehrawat S, Rouse B (2011) Tregs and infections: on the potential value of modifying their function. J Leukoc Biol 90:1079-1087.
46. Krause P, Bialek S, Boppana S, Griffiths PD, Laughlin C, et al. (2013) Priorities for CMV vaccine development. Vaccine 32:4-10.
47. Mitchell R, Taylor G, McGeer A, Frenette C, Suh K, et al. (2013) Understanding the burden of influenza infection among adults in Canadian hospitals: a comparison of the 2009-2010 pandemic season with the prepandemic and postpandemic seasons. Am J Infect Control 41:1032-1037.
48. Jackson L, Jackson M, Nelson J, Neuzil K, Weiss N (2006) Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 35:337-344.
49. Jackson L, Nelson J, Benson P, Neuzil K, Reid R, et al. (2006) Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 35:345-352.
50. Bennette C, Vickers A (2012) Against quantiles: categorization of continuous variables in epidemiologic research, and its discontents. BMC Med Res Methodol 12:21.
51. Izaks G, Remarque E, Becker S, Westendorp R (2003) Lymphocyte count and mortality risk in older persons. The Leiden 85-plus study. J Am Geriatr Soc 51:1461-1465.
52. Leng S, Xue Q, Tian J, Huang Y, Yeh S, et al. (2009) Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: results from the Women's Health and Aging Studies I. Experimental Gerontol 44:511-516.
53. Collerton J, Martin-Ruiz C, Davies K, Hilkens C, Isaacs J, et al. (2012) Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ study. Mech Ageing Dev 133:456-466.
54. Wang G, Kao W, Murakami P, Xue Q, Chiou R, et al. (2010) Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am J Epidemiol 171:1144-1152.
55. Mathei C, Vaes B, Wallemacq P, Degryse J (2011) Associations between cytomegalovirus infection and functional impairment and frailty in the BEFRAIL cohort. J Am Geriatr Soc 59:2201-2208.
56. Berry S, Ngo L, Samelson E, Kiel D (2010) Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc 58:783-787.